Cravath, Swaine & Moore is serving as legal counsel to Johnson & Johnson, while Skadden is serving as legal counsel to Ambrx Biopharma on the transaction....
Johnson & Johnson’s Acquisition of Ambrx Biopharma
Ambrx Biopharma’s $126 Million IPO
Goodwin Procter LLP and JunHe advised Goldman Sachs & Co. LLC and the other underwriters on the deal, while Wilson Sonsini Goodrich & Rosati and Maples...